Disc Medicine, Inc. (IRON)
USD 63.5
(-2.31%)
USD 63.5
(-2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -73.46 Million | -42.25 Million | -27.53 Million | -32.7 Million |
| Net Income | -76.42 Million | -46.82 Million | -35.96 Million | -40.83 Million |
| Depreciation & Amortization | 100 Thousand | 89 Thousand | 32 Thousand | 322 Thousand |
| Deferred income taxes | - | - | 5.05 Million | 8000.00 |
| Stock-based compensation | 5530.00 | 2089.00 | 507.00 | 123.00 |
| Change in working capital | -2.95 Million | 2.12 Million | 1.28 Million | 337 Thousand |
| Other non-cash items | 290 Thousand | 272 Thousand | 1.56 Million | 6.47 Million |
| Investing Cash Flow | -89 Thousand | -151 Thousand | -68 Thousand | -22 Thousand |
| Investments in PPE | -89 Thousand | -151 Thousand | -68 Thousand | -22 Thousand |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 239.37 Thousand | 148.97 Million | 89.92 Million | 34.24 Million |
| Debt repayment | - | - | -4.58 Million | -14 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 199.07 Million | 53.5 Million | 89.92 Million | 20.24 Million |
| Other Financing Activities | 239.37 Thousand | 95.47 Million | 4.58 Million | 28 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | -3.74 Million | 526 Thousand | 1.31 Million | -2.4 Million |
| Inventory | - | - | - | - |
| Other working capital | 788 Thousand | 1.59 Million | -29 Thousand | 2.74 Million |
| Cash at beginning of period | 194.78 Million | 88.21 Million | 25.88 Million | 3.3 Million |
| Cash at end of period | 360.61 Million | 194.78 Million | 88.21 Million | 4.82 Million |
| Capital Expenditure | -89 Thousand | -151 Thousand | -68 Thousand | -22 Thousand |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 165.82 Million | 106.57 Million | 62.32 Million | 1.51 Million |
| Free Cash Flow | -73.55 Million | -42.4 Million | -27.6 Million | -32.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.35 Million | -26.94 Million | -76.42 Million | -23.57 Million | -14.12 Million | -15.94 Million |
| Depreciation & Amortization | 110 Thousand | 26 Thousand | 100 Thousand | 25 Thousand | 25 Thousand | 25 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.09 Million | 4058.00 | 5530.00 | 1927.00 | 1270.00 | 1309.00 |
| Change in working capital | 7.2 Million | -10.87 Million | -2.95 Million | 5.22 Million | 5.3 Million | 339 Thousand |
| Other non-cash items | 152 Thousand | 142 Thousand | 290 Thousand | -1.39 Million | 46 Thousand | 1.55 Million |
| Investing Cash Flow | -219.74 Million | -67 Thousand | -89 Thousand | -3000.00 | -45 Thousand | -12 Thousand |
| Investments in PPE | 3.00 | -67 Thousand | -89 Thousand | -3000.00 | -45 Thousand | -12 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -219.75 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -219.75 Thousand | - | - | - | - | - |
| Financing Cash Flow | 173.19 Million | 15.9 Million | 239.37 Thousand | 7758.00 | 460.00 | 153.85 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 172.62 Million | 14.84 Million | 199.07 Million | 6.95 Million | 460 Thousand | 153.85 Million |
| Other Financing Activities | 173.19 Thousand | 15.9 Thousand | 239.37 Thousand | 7758.00 | 460.00 | 153.85 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -669 Thousand | -7.36 Million | -3.74 Million | 3.96 Million | 3.76 Million | -726 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 7871.00 | -3516.00 | 788 Thousand | 1.25 Million | 1.53 Million | 1.06 Million |
| Cash at beginning of period | 342.85 Million | 360.61 Million | 194.78 Million | 370.65 Million | 377.71 Million | 236.59 Million |
| Cash at end of period | 280.89 Million | 342.85 Million | 360.61 Million | 360.61 Million | 370.65 Million | 377.71 Million |
| Capital Expenditure | 3.00 | -67 Thousand | -89 Thousand | -3000.00 | -45 Thousand | -12 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -61.95 Million | -17.76 Million | 165.82 Million | -10.04 Million | -7.06 Million | 141.11 Million |
| Free Cash Flow | -15.39 Million | -33.66 Million | -73.55 Million | -17.79 Million | -7.52 Million | -12.73 Million |
SLTFF
APCXW
LPCUF
FSXLF
7990
VGMIF